ESPOO, Finland--(EON: Enhanced Online News)--Mobidiag Ltd, a Finnish molecular diagnostics company, today announced an agreement with AB ANALITICA, specialized in the development and the sale of diagnostic systems for professional use, for the distribution of the Amplidiag® product line. Under this three-year agreement, AB ANALITICA becomes the exclusive distributor of Amplidiag®, in vitro diagnostics for gastrointestinal infections, in Italy.
“AB ANALITICA has over 25 years of experience in the diagnostic market and is renowned for providing high-quality molecular diagnostic solutions. The agreement with Mobidiag enables us to complete our product offering to customers with an extensive range of IVD tests and instruments for infections found in stool samples”
“For the past months, we have been significantly extending our in vitro diagnostics suite of products. In order to make our IVD tests and instruments accessible throughout Europe, we are continuing the expansion of our distributor network to be able to support our customers more locally. With strong background in clinical microbiology and molecular diagnostics and a wide sales network, AB ANALITICA is the right partner to distribute our products in Italy”, said Tuomas Tenkanen, CEO at Mobidiag.
“AB ANALITICA has over 25 years of experience in the diagnostic market and is renowned for providing high-quality molecular diagnostic solutions. The agreement with Mobidiag enables us to complete our product offering to customers with an extensive range of IVD tests and instruments for infections found in stool samples” from Mikkel Johansen, Managing director at AB ANALITICA.
The distribution agreement is effective immediately and covers all Amplidiag® IVD tests (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and the two upcoming tests; Amplidiag® Viral GE and Amplidiag® CarbaR+MCR) as well as the Amplidiag® Easy system.
About Mobidiag Ltd.
Established in 2000, Mobidiag develops innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland.
Mobidiag addresses both high to medium volume screening with the new Amplidiag® Easy platform, bringing the Amplidiag® suite further by automating the workflow from sample to results, and the upcoming Novodiag® platform & associated panels for a fully automated solution and suitable for smaller volumes and labs. Visit www.mobidiag.com.
About AB ANALITICA
AB ANALITICA was established in the year 1990 in Padua in the Veneto region (Italy) and is a company specialized in the development and the sale of diagnostic systems for professional use. Main competences cover diagnostics based on qualitative and quantitative determination of nucleic acids by molecular biology methods, the development and implementation of biobanking management systems as well as in vivo and in vitro diagnostics using breath test and stable isotopes. AB ANALITICA has a sales agent network that covers the entire Italian territory and collaborate with local distributors in many export countries.